Literature DB >> 20646514

[Effect of optimizing anesthetic injecting sequence during induction on fentanyl-induced coughing].

Lei Wang1, Jin-hua Yao, Jun-jian Zhu, Bin Liu, Jian-guo Zhu, Da-chun Zhou.   

Abstract

OBJECTIVE: To observe the effect of optimizing anesthetic injecting sequence during induction on fentanyl-induced coughing.
METHODS: One hundred and twenty ASA I or II elective patients undergoing general anesthesia were randomly allocated to optimized group or control group: the optimized group induced with midazolam 0.06 mg/kg, followed by fentanyl 1 mg/kg at 1 min later, vecuronium 0.1 mg/kg at 1 min 55 s, propofol 1.5-2 mg/kg at 2 min, a second dose of 3 mg/kg fentanyl at 2 min 20 s, intubated at time 5 min; the control group was induced with the same medication but all the fentanyl (4 mg/kg) was injected at time 1 min. Coughing after fentanyl injection was observed and hemodynamic parameters were recorded.
RESULTS: Hemodynamic changes were identical between the two groups indicated similar intubation response suppression. The incidence of fentanyl-induced coughing was significantly lower in the optimized group (4/60) than in the control group (23/60) (P < 0.01).
CONCLUSION: Optimizing anesthetic injecting sequence during induction by separate fentanyl into two boluses significantly reduce fentanyl-induced coughing without affecting intubation response suppression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646514

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  Pre-emptive small dose of fentanyl suppresses fentanyl-induced cough: a meta-analysis of randomized controlled trials.

Authors:  Bo-Xiang Du; Liang Cao; Wei-Liang Zhao; Zhi-Hua Xu; Jie Song; Xue-Yin Shi
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Effects of pretreatment with a small dose of dexmedetomidine on sufentanil-induced cough during anesthetic induction.

Authors:  Shen Sun; Shao-qiang Huang
Journal:  J Anesth       Date:  2012-08-25       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.